Effects of a cocaine hydrolase engineered from human butyrylcholinesterase on metabolic profile of cocaine in rats
- 1 November 2016
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 259, 104-109
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 27 references indexed in Scilit:
- Assessment of Pharmacokinetic and Pharmacodynamic Interactions Between Albumin-Fused Mutated Butyrylcholinesterase and Intravenously Administered Cocaine in Recreational Cocaine UsersJournal of Clinical Psychopharmacology, 2015
- Pharmacotherapy: Quest for the quitting pillNature, 2015
- Editorial (Thematic Issue: Emerging Targets for Stimulant Use Disorders: Where To Invest In An Era Of Constrained Resources?)CNS & Neurological Disorders - Drug Targets, 2015
- Safety, pharmacokinetics, and pharmacodynamics of TV‐1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjectsThe Journal of Clinical Pharmacology, 2015
- Preparation and in vivo characterization of a cocaine hydrolase engineered from human butyrylcholinesterase for metabolizing cocaineBiochemical Journal, 2013
- Modeling of Pharmacokinetics of Cocaine in Human Reveals the Feasibility for Development of Enzyme Therapies for Drugs of AbusePLOS Computational Biology, 2012
- Wiping Drug MemoriesScience, 2012
- Abnormal Brain Structure Implicated in Stimulant Drug AddictionScience, 2012
- Fundamental Reaction Mechanism for Cocaine Hydrolysis in Human ButyrylcholinesteraseJournal of the American Chemical Society, 2003
- Relationship between subjective effects of cocaine and dopamine transporter occupancyNature, 1997